Latest FDA Stories
On Dec. 22 and 23 the FDA released two important guidances regarding the management of human cells, tissues and cellular/tissue based products (HCT/P). Join FDAnews on Feb.
- Proposed label expansion would support use of TEFLARO in cases of acute bacterial skin and skin structure infections (ABSSSI) with concurrent bacteremia - DUBLIN, Feb.
First Ever Cone Beam Breast CT for Diagnostic Imaging of the Breast ROCHESTER, N.Y., Feb.
Former head of CMS and FDA to advance West Health's efforts to transform healthcare delivery and lower the cost of healthcare SAN DIEGO and WASHINGTON, Feb.
RICHMOND, Calif., Feb. 4, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
A former U.S.
FDA’s new plans to create specialized teams of investigators — their composition and expertise based on specific products — are going to put more pressure on SMEs than ever before.
SAN FRANCISCO, Feb. 3, 2015 /PRNewswire/ -- Napo Pharmaceuticals, Inc.
SCOTTSDALE, Ariz., Feb.
There have been 1,458 implants of 13 different artificial heart designs performed between 1969 and 2014.
- A political dynamiter.